bleomycin

enterica cell extract significantly and selectively alters the expression of TOP, a critical cytosolic peptidase involved in the final stages of antigen processing. This targeted modulation likely serves as a mechanism for immune evasion by facilitating the destruction of immunogenic epitopes, thereby rendering infected cells less visible to the adaptive immune system.

Sirolimus was initiated but clinical deterioration continued within days, leading to the decision to provide interventional management. CONCLUSIONS Bleomycin sclerotherapy may be an effective and safe therapeutic option for propranolol resistance ulcerated infantile hemangiomas that fail conventional medical therapy. Early multidisciplinary evaluation and timely escalation to interventional treatment may help prevent progressive tissue destruction and improve functional and cosmetic outcomes in selected refractory cases.

Postpartum positron emission tomography/computed tomography demonstrated extensive supradiaphragmatic disease, and chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine was promptly initiated. The patient showed a favorable clinical and metabolic response, and the neonate demonstrated normal early postnatal development. This case highlights the importance of early recognition and multidisciplinary management of superior vena cava syndrome in pregnancy and raises the hypothesis that pregnancy-associated immunologic changes, including interleukin-6-mediated pathways, may contribute to accelerated disease progression.

P=N/A, N=0, Withdrawn, Istituto Ortopedico Rizzoli | N=30 --> 0 | Trial completion date: Aug 2029 --> Aug 2025 | Recruiting --> Withdrawn | Trial primary completion date: Aug 2028 --> Aug 2025

P2, N=140, Not yet recruiting, Institute of Oncology Ljubljana

This study aimed to evaluate the novel Affibody molecule-based positron emission tomography (PET) tracer [68Ga]Z0185, targeting TNF, for its ability to detect inflammation in vivo using the bleomycin (BLM)-induced lung injury model in rats...[68Ga]Z0185 bound to recombinant human TNF in vitro with a mechanism that could be partially inhibited by etanercept (131.8 ± 12.0 vs. 74.2 ± 5.6 fmol, P < 0.05)...&lsqb;68Ga]Z0185 enables non-invasive detection of localized TNF-driven inflammation in the lung. This approach offers a promising imaging tool for patient stratification, therapy monitoring, and guiding anti-TNF interventions in pulmonary diseases.

Post-operatively, tumour markers declined significantly, and the patient was commenced on bleomycin, etoposide, and cisplatin chemotherapy. This case emphasizes that painful scrotal swelling does not exclude malignancy and highlights the importance of early recognition and multidisciplinary management.

P2, N=340, Active, not recruiting, Merck Sharp & Dohme LLC | N=243 --> 340

Autophagy flow was assessed by western blot and Ad-mCherry-GFP-LC3B dual-fluorescence system and validated by lysosome inhibitor barfimycin A1 and autophagy inducer rapamycin...Compared with the control group, MUC1 knockout led to a significant increase of autophagy-related proteins LC3-II and p62, which is consistent with the effect of lysosome inhibitor bleomycin A1...The expression level of LAMP1 was downregulated and the lysosome pH increased, but the expression levels of STXl7 and SNAP29 were not affected. These findings suggest that MUC1 promotes malignant behaviors in MDA-MB-231 cells by regulating autophagic flow, likely through lysosomal dysfunction-mediated autophagy blockade.

B1-21 cells were particularly sensitive to camptothecin and the PARP inhibitor NU1025, whereas V-C8 cells showed higher sensitivity to etoposide, cisplatin, mitomycin C, and bleomycin. These findings indicate that partial disruption of the BRCA1 RING domain results in a hypomorphic phenotype with impaired homologous recombination, defective checkpoint control, and enhanced genotoxic sensitivity. The isogenic BRCA1 and BRCA2 mutant V79 lines offer a valuable model for dissecting DDR pathway differences and developing mutation-specific therapeutic strategies targeting BRCA-mutant cancers.

After complete (CS) or partial (PS) surgery, the patients received post-surgical bed injections of (i) lipoplexes carrying canine interferon-β (cIFNβ) gene combined with bleomycin (CTIF/B) or (ii) 5-fluorouracil (CT5FU). Both surgery adjuvant treatments delayed or prevented post-surgical recurrence and metastases, improved disease-free and overall survival while maintaining quality of life. These successful outcomes encourage assaying a similar scheme for human melanoma.

P=N/A, N=10, Peking University School and Hospital of Stomatology; Peking University School and Hospital of Stomatology